Skip to Content

WATSON 761 (Ranitidine Hydrochloride 300 mg)

Pill with imprint WATSON 761 is Beige, Elliptical / Oval and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Watson Pharmaceuticals.

Ranitidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; gastric ulcer maintenance treatment; eczema (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 761

Ranitidine hydrochloride 300 mg WATSON 761

Ranitidine Hydrochloride

Imprint:
WATSON 761
Strength:
300 mg
Color:
Beige
Size:
16.00 mm
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:
silicon dioxide colloidal
hypromellose
magnesium stearate
maltodextrin
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium bicarbonate
synthetic ferric oxide red
synthetic ferric oxide yellow
magnesium silicate
titanium dioxide
triethyl citrate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide